J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 681.95 INR -1.94%
Market Cap: 261.2B INR
Have any thoughts about
J B Chemicals and Pharmaceuticals Ltd?
Write Note

J B Chemicals and Pharmaceuticals Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

J B Chemicals and Pharmaceuticals Ltd
Common Shares Outstanding Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Common Shares Outstanding
â‚ą155.2m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Common Shares Outstanding
â‚ą832.6m
CAGR 3-Years
71%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Common Shares Outstanding
â‚ą807.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Common Shares Outstanding
â‚ą2.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Common Shares Outstanding
â‚ą338.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
M
Mankind Pharma Ltd
NSE:MANKIND
Common Shares Outstanding
â‚ą400.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is J B Chemicals and Pharmaceuticals Ltd's Common Shares Outstanding?
Common Shares Outstanding
155.2m INR

Based on the financial report for Jun 30, 2024, J B Chemicals and Pharmaceuticals Ltd's Common Shares Outstanding amounts to 155.2m INR.

What is J B Chemicals and Pharmaceuticals Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 3Y
26%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for J B Chemicals and Pharmaceuticals Ltd have been 26% over the past three years .

Back to Top